Insights

The UPC and Unitary Patent: April 2018 update

by Dr Paul England

Brexit and the life sciences: April 2018 update

by Matthew Royle, Ph.D. and Dr Paul England

Licence held to be exclusive despite option

by Andrew Payne

Inventive step in Europe and the UPC

by Dr Paul England

Advocate General considers prescription support software to be a medical device

by Evelyne Friedel and Tasmina Goraya, PhD

Unjustified threats of patent infringement – changes to UK law

by Michael Washbrook

Rezeptortyrosinkinase II: Patent protection for a test method does not extend to test results

by Dr. Dietrich Kamlah

Pemetrexed in Germany: Federal Court of Justice sets aside decision of Appeal Court

by Christoph de Coster, LL.M. (UC Davis) and Julius Zacharias

“E-Health Law” in Germany

by Dr. Wolfgang Rehmann

Intellectual Property in the Life Sciences, in review

by Dr Paul England

Supreme Court ruling on penalty clauses: consequences for bad leaver provisions

by Debbie Cloake

Strategic considerations - why opt-out or why not?

by Dr. Anja Lunze, LL.M.